Answer these two questions, and we will help you find care that is right for you.

Please make sure you update age and diagnosis.

“If you asked me on a scale of 1 to 10, where I would place Skyland Trail in my recovery, I would give it a 15.”

– Bill L.

Treatment Outcomes

Skyland Trail is a trailblazer in the area of outcomes research, which is an integral part of our evidence-based treatment model. Our robust outcomes and research program employs evaluative instruments considered to be the gold standards in the mental health field to measure the effectiveness of our treatment programs. Outcome data from 2008 through 2016 confirm that our unique integrated, whole person approach helps our clients grow, recover, and reclaim their lives. People who complete the treatment program at Skyland Trail return to their communities with reduced symptoms and improved skills to pursue more independent and productive lives.

When clients begin treatment at Skyland Trail, they complete tests measuring their symptom severity, attitude toward medication adherence, hope for the future, level of functioning, senses of self efficacy and relationships with others, and physical health. We measure those indicators again when they complete their treatment. We supplement these measurements with annual satisfaction surveys.

Specialized instruments based on diagnoses and symptoms provide a more detailed picture of the effectiveness of specific treatment programs for bipolar illness, major depression, schizophrenia, and anxiety.

Who We Treat

Client diagnosesWe treat adults ages 18 and older with a primary psychiatric diagnosis. In 2016,  72% of clients had 3 or more co-occurring diagnoses – including anxiety disorders, substance use disorders, and personality disorders – in addition to a mood or thought disorder. Admissions criteria >

2016 Key Outcomes

  • 90% of all clients experienced a statistically significant improvement in their attitude toward activities of daily living & overall functioning
  • 84% of clients with anxiety experienced statistically significant improvement in control of anxiety
  • 83% of clients left treatment with a positive attitude about taking psychiatric medication
  • 80% of all clients experienced a statistically significant improvement in feelings of hopelessness
  • 90% of clients with depression experienced statistically significant improvement
  • 81% of clients with mania experienced statistically significant reduction of their manic symptoms

Publications: 2016 Outcomes Report

Research & Publications

Poster: Screening, Delivering and Measuring Outcomes For Cognitive Remediation Training in a Private Non-Profit Community Mental Health Setting
Presented: IPS, The Mental Health Services Conference 2017
View >

Article: Measuring and Facilitating Client Engagement with Financial Incentives: Implications for Improving Clinical Outcomes in a Mental Health Setting
Community Mental Health Journal 2016;9: 1-9
View >

Article: Systematic Study of Structured Diagnostic Procedures in Outpatient Psychiatric Rehabilitation: A Three-year, Three-cohort Study of the Stability of Psychiatric Diagnoses
Innovations in Clinical Neuroscience 2013;10(5-6):14-19
View >

Poster: A Model Wellness Intervention Aimed at Reducing Cardiometabolic Syndrome Risk Associated with Psychotropic Medications
Presented: APA Annual Meeting 2015
View >

Poster: A Longitudinal Analysis of Patients’ Perceptions of Life Events After Discharge from Community Mental Health Services
Presented: APA Annual Meeting 2014
View >

Poster: Engagement Trajectories in Community-Based Mental Health Service Delivery: The Role of Financial Incentives
Presented: APA Institute on Psychiatric Services Annual Meeting 2013
View >

Poster: Engagement Trajectories in Community-Based Mental Health Service Delivery: The Role of Financial Incentives
Presented: APA Annual Meeting 2013
View >